Abstract | BACKGROUND: METHODS: A ten year old boy with cyclic neutropenia was initially treated with G-CSF 7 micrograms/kg given on alternate days for seven months. He was then placed on the same dose, given three days a week. The effectiveness of these regimens were assessed by serial CBCs and by the frequency and duration of the symptoms. RESULTS: The mean absolute neutrophil count (ANC) increased from 1282 before therapy to 11,718/microliters on alternate day regimen and 7716/microliters on three-day-a-week regimen. The nadir ANC improved from 30/microliters before therapy to 546/microliters and 198/microliters on treatment. The duration and frequency of mouth sores were significantly less on therapy, and there was an estimated cost savings of $23,826/year on three-day-a-week regimen compared to a daily regimen. CONCLUSION: The three-day-a-week G-CSF regimen is clinically effective and cost saving in the treatment of cyclic neutropenia and should be studied in a larger cohort of patients.
|
Authors | S Jayabose, O Tugal, C Sandoval, K Li |
Journal | The American journal of pediatric hematology/oncology
(Am J Pediatr Hematol Oncol)
Vol. 16
Issue 4
Pg. 338-40
(Nov 1994)
ISSN: 0192-8562 [Print] United States |
PMID | 7526722
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Recombinant Proteins
- Granulocyte Colony-Stimulating Factor
|
Topics |
- Child
- Drug Administration Schedule
- Granulocyte Colony-Stimulating Factor
(administration & dosage, therapeutic use)
- Humans
- Male
- Neutropenia
(drug therapy)
- Periodicity
- Recombinant Proteins
(administration & dosage, therapeutic use)
|